SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

TARA

Protara Therapeutics Inc.
NASDAQHealth Care

Latest close: 2.32 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Aug 11, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
  2. Aug 11, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Jun 29, 2026Reported sale · Form 4Jesse Shefferman, CEO and President · $882.2KOpen the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record75415 flagged findings
Reported transactions (Form 4)80since Jan 19, 2024 · and 5 other holdings
Corporate events (8-K)30since Sep 24, 2019

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

What the company does

American pharmaceutical company

Source: Wikidata (CC0 1.0) · copied on Sep 3, 2026 · may not reflect recent changes.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 754)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Aug 13, 26SCHEDULE 13G/A ↗Passive stake · JANUS HENDERSON GROUP Ltd. · 8.4% · event on Jun 30, 26 · amendment
  • Aug 11, 2610-Q ↗Quarterly report
  • Aug 11, 268-K ↗Current report · Results
  • Jul 7, 26SCHEDULE 13G/A ↗Passive stake · Millennium Management LLC · 5.7% · event on Jul 1, 26 · amendment
  • Jul 1, 26Form 4 ↗Insider transaction
  • Jun 29, 26Form 144 ↗Notice of proposed sale
  • Jun 29, 268-K ↗Current report · A senior executive left or was appointed
  • Insider transaction · 8 Form 4 filingsshow all 8hide
  • Jun 15, 268-K ↗Current report · Shareholder vote results
  • Jun 3, 26Form 4 ↗Insider transaction
  • May 28, 26424B5 ↗Securities offering
  • May 20, 26CORRESP ↗Correspondence with the SEC
  • May 19, 26UPLOAD ↗Correspondence with the SEC
  • May 15, 26SCHEDULE 13G/A ↗Passive stake · JANUS HENDERSON GROUP PLC · 9.6% · event on Mar 31, 26 · amendment
  • May 14, 26S-3 ↗Securities offering
  • May 13, 2610-Q ↗Quarterly report
  • May 13, 268-K ↗Current report · Results
  • Apr 28, 26DEFA14A ↗Shareholder meeting and votes

754 filings on record, the oldest from Jul 23, 14.

Listing the 25 most recent filings of the 754 on record.

8-Ks, explained

Stress3Structure19Governance26
  • Jun 29, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Structure3 material agreements entered2024 – 2025show all 3hide
    • Dec 8, 25StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
    • Dec 11, 24StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
    • Apr 5, 24StructureEntered a material agreement+4 more in the same filing8-K 1.01 ↗
  • Governance8 senior executive changes2021 – 2024show all 8hide
    • Mar 18, 24GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Jan 30, 23GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Jul 18, 22GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Jun 21, 22GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Jan 10, 22GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Oct 18, 21GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Jun 10, 21GovernanceA senior executive left or was appointed+3 more in the same filing8-K 5.02 ↗
    • Apr 19, 21GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Mar 17, 21GovernanceAuditor change filing (8-K Item 4.01)+1 more in the same filing8-K 4.01 ↗
  • Feb 2, 21GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Dec 8, 20StructureEntered a material agreement8-K 1.01 ↗
  • Dec 7, 20GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Sep 23, 20StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Jul 24, 20GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Jul 16, 20StructureEntered a material agreement8-K 1.01 ↗
  • Mar 23, 20GovernanceAuditor change filing (8-K Item 4.01)+1 more in the same filing8-K 4.01 ↗
  • Feb 11, 20GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗

5 older filings not shown · The record reaches back to Jun 2, 15.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

The full record holds 3 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • JANUS HENDERSON GROUP Ltd.8.4%Jun 30, 26SCHEDULE 13G/A ↗6 earlier filings
  • BlackRock, Inc.6.3%Mar 31, 26SCHEDULE 13G ↗2 earlier filings
  • Millennium Management LLC5.7%Jul 1, 26SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • RA Capital Management, L.P.4.9%Jun 30, 25SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
  • Opaleye Management, Inc.4.7%Mar 31, 25SCHEDULE 13G/A ↗

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Sale intention announced

On Jun 29, JESSE SHEFFERMAN filed notice of intent to sell up to $882K. That is about 0.38% of shares outstanding.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

After the notice, they sold $882K on Jun 29, per their Form 4. That is 100% of the shares announced.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Jun 29, 26Sell$882KJesse SheffermanCEO and President↗
  • Apr 8, 26Sell$6KJacqueline ZummoChief R&D Officer↗
  • Apr 1, 26Sell$119KJacqueline ZummoChief R&D Officer↗
  • May 14, 25Buy$64KRichard S Levy↗
  • Mar 26, 25Sell$96KJacqueline ZummoChf Scientific Operations Off↗
Stock compensation, tax and giftsshow the 35 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Jun 30, 26Giftamount n/aJesse SheffermanCEO and President↗
  • Jun 30, 26Giftamount n/aJesse SheffermanCEO and President↗
  • Jun 30, 26Giftamount n/aJesse SheffermanCEO and President↗
  • Jun 30, 26Giftamount n/aJesse SheffermanCEO and President↗
  • Jun 29, 26Compensation$412KJesse SheffermanCEO and President↗
  • Jun 2, 26Tax$26KWILLIAM CONKLINGChief Commercial Officer↗
  • Jan 26, 26Tax$22KPatrick FabbioChief Financial Officer↗
  • Jan 26, 26Tax$10KHannah FryVP, Controller↗
  • Jan 26, 26Tax$25KJacqueline ZummoChf Scientific Operations Off↗
  • Jan 26, 26Tax$58KJesse SheffermanCEO and President↗
  • Jan 20, 26Tax$12KHannah FryVP, Controller↗
  • Jan 20, 26Tax$37KJacqueline ZummoChf Scientific Operations Off↗
  • Jan 20, 26Tax$17KPatrick FabbioChief Financial Officer↗
  • Jan 20, 26Tax$91KJesse SheffermanCEO and President↗
  • Jan 16, 26Compensationamount n/aJacqueline ZummoChf Scientific Operations Off↗
  • Jan 16, 26Compensationamount n/aJesse SheffermanCEO and President↗
  • Jan 16, 26Compensationamount n/aLeonardo Viana NicacioChief Medical Officer↗
  • Jan 16, 26Compensationamount n/aHannah FryVP, Controller↗
  • Jan 16, 26Compensationamount n/aPatrick FabbioChief Financial Officer↗
  • Jan 16, 26Compensationamount n/aWILLIAM CONKLINGChief Commercial Officer↗
  • Jun 27, 25Giftamount n/aJesse SheffermanCEO and President↗
  • Jun 27, 25Giftamount n/aJesse SheffermanCEO and President↗
  • Jun 26, 25Giftamount n/aJesse SheffermanCEO and President↗
  • Jun 26, 25Giftamount n/aJesse SheffermanCEO and President↗
  • Jun 24, 25Giftamount n/aJesse SheffermanCEO and President↗
  • Jun 2, 25Compensationamount n/aWILLIAM CONKLINGChief Commercial Officer↗
  • Apr 15, 25Compensationamount n/aLeonardo Viana NicacioChief Medical Officer↗
  • Jan 24, 25Compensationamount n/aPatrick FabbioChief Financial Officer↗
  • Jan 24, 25Compensationamount n/aHannah FryVP, Controller↗
  • Jan 24, 25Compensationamount n/aJacqueline ZummoChf Scientific Operations Off↗
  • Jan 24, 25Compensationamount n/aJesse SheffermanCEO and President↗
  • Jan 21, 25Tax$74KJesse SheffermanCEO and President↗
  • Jan 21, 25Tax$31KJacqueline ZummoChf Scientific Operations Off↗
  • Jan 21, 25Tax$10KHannah FryVP, Controller↗
  • Jan 21, 25Tax$15KPatrick FabbioChief Financial Officer↗

The full record holds 111 transactions and goes back to Jun 27, 22.

Its sector and its market

Protara Therapeutics Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Protara Therapeutics Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Protara Therapeutics Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
754 documents on file, from Jul 23, 2014 to Aug 13, 2026.
Company description
Wikidata, read on Sep 3, 2026.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.